# PROCEPT BioRobotics Corporation (PRCT) · Edgar & Edgarette company card

> PROCEPT BioRobotics (PRCT) grew revenue 37.2% in FY2025 to $308 million, operating margin -33.7% against a 1.2% median for surgical & medical instruments & apparatus, equity 72.0% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1588978 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/PRCT) · [JSON](https://www.pops4.com/boards/company/PRCT.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $308M |
| Revenue growth, 1 year | 37.2% |
| Revenue growth per year | 72.9% |
| Operating margin | -33.7% (prior year -43.0%) |
| Net margin | -31.0% |
| Operating cash flow | −$49M |
| Capital spending | $9M |
| Free cash flow | −$58M |
| Cash | $287M |
| Long-term debt | $52M |
| Total assets | $508M |
| Total equity | $366M |
| Equity ÷ assets | 72.0% |
| Return on equity | -26.1% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: 2.18 (grey zone)
- Piotroski F: 3 of 9 (middling)
- Beneish M: -2.86 (below the −1.78 line)
- Health Harbor boat: Weathered boat · two warning signs · operating cash flow was negative; operating loss: a margin of -33.7% in FY2025
- Cash Compass: Fast, cash not yet · growing fast, but little cash arriving so far

## Edgarette's reading

Exposure: revenue $308.1M (FY2025), total debt $51.6M. Experience: revenue up 37.2% on the year, up 72.9% a year over 4 years; operating margin -33.7%, up from -43.0%. Soundness: equity 72.0% of assets, return on equity -26.1%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $349.5M and $579.0M next year (method v4.1: its own 4-year record of growth weighed at 50% against $100M–1B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $307.6M to $661.2M. A statistical range, not company guidance. Against peers (60 filers, $50M+ revenue, surgical & medical instruments & apparatus): operating margin -33.7% against a 1.2% median; growth 37.2% against 11.6%.

Range logged 2026-09-25, receipt 432b338747969671, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 2, latest 2026-10-02 ([filing](https://www.sec.gov/Archives/edgar/data/1588978/000162828026064586/0001628280-26-064586-index.htm))

## Recent filings

- 10-Q · filed 2026-11-04 · [filing](https://www.sec.gov/Archives/edgar/data/1588978/000158897826000039/0001588978-26-000039-index.htm)
- 8-K · filed 2026-11-04 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1588978/000158897826000036/0001588978-26-000036-index.htm)
- 8-K · filed 2026-10-02 · 5.02 Departure or Election of Directors; Appointment of Officers; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1588978/000162828026064586/0001628280-26-064586-index.htm)
- 8-K · filed 2026-09-24 · 1.01 Entry into a Material Definitive Agreement; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1588978/000158897826000034/0001588978-26-000034-index.htm)
- 10-Q · filed 2026-08-05 · [filing](https://www.sec.gov/Archives/edgar/data/1588978/000158897826000030/0001588978-26-000030-index.htm)
- 8-K · filed 2026-08-04 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1588978/000158897826000028/0001588978-26-000028-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001588978.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1588978

## Cite

POPS4, Edgar & Edgarette: PROCEPT BioRobotics Corporation (PRCT) company card, from the company's own SEC filings, accessed 2026-11-09, https://www.pops4.com/boards/company/PRCT. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.